Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Dual-Tracer Theranostic PET

NCT05680675

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors

NCT02691078

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Instituto do Cérebro do Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Completed

Cabozantinib and Nivolumab for Carcinoid Tumors

NCT04197310

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumor of GI System, +8 more
Locations: Boston Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study

NCT05013957

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University Hospital Basel, Department of Endocrinology Basel, Canton of Basel-City, Switzerland

View Trial Details

Completed

Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs

NCT04696042

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Changhoon Yoo Seoul, South Korea

View Trial Details

Completed

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

NCT04524442

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations: Istituto Europeo di Oncologia Milan, MI, Italy

Erasmus University Medical Center Rotterdam, Gelderland, Netherlands

Gammed-Centrum Diagnostyczno-Lecznicze Warsaw, Poland

University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom

View Trial Details

Completed

The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine Tumor

NCT06779708

Conditions: Liver Metastasis, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Humanitas Research Hospital Rozzano, Milan, Italy

View Trial Details

Completed

Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors

NCT02736500

Conditions: Gastro Entero Pancreatic Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Giovanni Paganelli Meldola, FC, Italy

Lisa Bodei Milan, Italy

View Trial Details

Completed

Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.

NCT03980925

Conditions: Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +6 more
Locations: Institut Català d'Oncologia Badalona Badalona, Barcelona, Spain

Institut Català d'Oncologia l'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain

Vall d'Hebron University Hospital Barcelona, Spain

Hospital Universitario 12 de Octubre Madrid, Spain

View Trial Details

Completed

Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin

NCT03095274

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Instituto Catalán de Oncología Badalona Badalona, Barcelona, Spain

Complejo Hospitalario de Navarra Pamplona, Navarre, Spain

Hospital Universitario Marqués de Valdecilla Santander, Principality of Asturias, Spain

Hospital Duran i Reynals/ICO L'Hospitalet Barcelona, Spain

View all 19 locations

View Trial Details